Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia

This publication has 100 references indexed in Scilit:

• Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
  Bone Marrow Transplantation, 2000
• Modulation of cIAP-1 by Novel Antitubulin Agents When Combined with Bryostatin 1 Results in Increased Apoptosis in the Human Early Pre-B Acute Lymphoblastic Leukemia Cell Line Reh
  Biochemical and Biophysical Research Communications, 1999
• Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft
  Bone Marrow Transplantation, 1999
• FLAG (Fludarabine, Cytarabine, G‐CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects
  European Journal of Haematology, 1996
• Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors
  British Journal of Haematology, 1994
• High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis
  Annals of Hematology, 1994
• Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia
  Cancer, 1993
• Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia
  Cancer, 1989
• Relationship between leukemic cell retention of cytosine arabinoside triphosphate and the duration of remission in patients with acute non-lymphocytic leukemia
  European Journal of Cancer and Clinical Oncology, 1985
• High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia
  Medical and Pediatric Oncology, 1978